Matthias Schwab

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen

Affiliated withDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen University of Tuebingen German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tuebingen

Research Area

Cancer Research

Biography

Matthias Schwab has not added Biography.
If you are Matthias Schwab and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PloS one\| PubMed ID: 19823678	2009
Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis. PloS one\| PubMed ID: 21949869	2011
Simultaneous quantification of mefloquine (+)- and (-)-enantiomers and the carboxy metabolite in dried blood spots by liquid chromatography/tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences\| PubMed ID: 24315337	2014
LC-MS/MS method for the simultaneous quantification of artesunate and its metabolites dihydroartemisinin and dihydroartemisinin glucuronide in human plasma. Analytical and bioanalytical chemistry\| PubMed ID: 24760398	2014
Tubular breast cancer. A retrospective study. Anticancer research\| PubMed ID: 24982382	2014
Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease. Journal of the American Heart Association\| PubMed ID: 26475297	2015
Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest. Cancer research\| PubMed ID: 27013194	2016
Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors. Trends in pharmacological sciences\| PubMed ID: 27659854	2016
Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin". Science translational medicine\| PubMed ID: 28539468	2017
Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters. Epilepsy research\| PubMed ID: 28624574	2017
[Metabolomics and Cancer]. Der Pathologe\| PubMed ID: 29138896	2017
Neuroprotective, Neurogenic, and Amyloid Beta Reducing Effect of a Novel Alpha 2-Adrenoblocker, Mesedin, on Astroglia and Neuronal Progenitors upon Hypoxia and Glutamate Exposure. International journal of molecular sciences\| PubMed ID: 29267189	2017
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. European urology focus\| PubMed ID: 29452772	2019
Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs. Epilepsy research\| PubMed ID: 29499473	2018
The fruit fly Drosophila melanogaster as an innovative preclinical ADME model for solute carrier membrane transporters, with consequences for pharmacology and drug therapy. Drug discovery today\| PubMed ID: 29890226	2018
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma. BMC medicine\| PubMed ID: 29973214	2018
Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer. Journal of clinical medicine\| PubMed ID: 30572653	2018
Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry. Genetics in medicine : official journal of the American College of Medical Genetics\| PubMed ID: 30728528	2019
Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease. Cells\| PubMed ID: 31208073	2019
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome medicine\| PubMed ID: 32228647	2020
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy. Genome medicine\| PubMed ID: 36109798	2022
The value of walking: a systematic review on mobility and healthcare costs. European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity\| PubMed ID: 36581809	2022
Re: Judikael R. Saout, Gwendoline Lecuyer, Simon Léonard, et al. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal... European urology\| PubMed ID: 37202315	2023
Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes. Annual review of pharmacology and toxicology\| PubMed ID: 37585662	2024
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation. Pharmacological research\| PubMed ID: 37775020	2023
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes. Pharmacological reviews\| PubMed ID: 39952686	2025
Personalized cancer vaccination is emerging: lessons learnt from renal cancer and challenges for broader application. Signal transduction and targeted therapy\| PubMed ID: 40199870	2025